首页 > 最新文献

Therapeutics and Clinical Risk Management最新文献

英文 中文
Potentially Risk Factors for New Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Grafting: A Retrospective Cohort Study. 冠状动脉旁路移植术患者新发心房颤动的潜在风险因素:回顾性队列研究
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-10-02 eCollection Date: 2024-01-01 DOI: 10.2147/TCRM.S473886
Aiwen Wang, Zhuo Yuan, Xingpeng Bu, Shuzhen Bi, Yadong Cheng, Huanzhen Chen

Objective: Our study evaluated the risk factors for new postoperative atrial fibrillation (POAF) by analyzing the data collected from patients who underwent first coronary artery bypass grafting (CABG).

Methods: Our study retrospectively collected data from January 2021 to December 2023 at Changzhi People's Hospital. The perioperative period data were collected, and logistic regression was used to analyze the independent predictors of the occurrence of POAF after CABG and the related predictive values of risk factors were analyzed by using the subjects' work characteristic curve (ROC).

Results: A total of 169 patients were included, and there are 45 patients in the POAF group, with an incidence of 26.6%, and 124 in the non-POAF group. The POAF group was significantly higher than the non-POAF group in terms of age (69.2±8.8 years vs 62.3±9.3 years) and preoperative LAD (42.7±7.2mm vs 36.8±5.5mm), and the difference was significant (P<0.05). Preoperative HDL-C in the POAF group were lower than non-POAF group (1.0±0.5 mmol/l vs 1.4±0.7 mmol/l, P<0.05). The logistic regression analysis revealed a significant correlation between age, LAD, HDL-C and the occurrence of POAF (P<0.05). According to the ROC curve analysis, age >64.5 years, LAD >41mm, and HDL-C <0.9 mmol/l were the cut-off values for predicting the occurrence of POAF (AUC1=0.733; AUC2=0.741; AUC3=0.647, P < 0.05). The combined age + LAD + HDL-C (AUC = 0.755; P < 0.05) had a higher diagnostic value and high sensitivity.

Conclusion: The age, LAD, and HDL-C are independent risk factors for the POAF after CABG, and clinicians should assess these risk factors as much as possible when managing patients in the perioperative period and make corresponding measures to prevent the development of POAF.

研究目的本研究通过分析首次接受冠状动脉搭桥术(CABG)患者的数据,评估术后新发房颤(POAF)的风险因素:我们的研究回顾性地收集了长治市人民医院2021年1月至2023年12月的数据。收集围手术期数据,采用Logistic回归分析CABG术后POAF发生的独立预测因素,并利用受试者工作特征曲线(ROC)分析危险因素的相关预测值:共纳入169例患者,其中POAF组45例,发生率为26.6%,非POAF组124例。POAF组在年龄(69.2±8.8岁 vs 62.3±9.3岁)和术前LAD(42.7±7.2mm vs 36.8±5.5mm)方面明显高于非POAF组,且差异显著(P64.5岁、LAD>41mm、HDL-C 结论:POAF组患者的年龄、LAD和HDL-C均明显高于非POAF组:年龄、LAD 和 HDL-C 是 CABG 术后发生 POAF 的独立危险因素,临床医生在围手术期管理患者时应尽可能评估这些危险因素,并采取相应措施预防 POAF 的发生。
{"title":"Potentially Risk Factors for New Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Grafting: A Retrospective Cohort Study.","authors":"Aiwen Wang, Zhuo Yuan, Xingpeng Bu, Shuzhen Bi, Yadong Cheng, Huanzhen Chen","doi":"10.2147/TCRM.S473886","DOIUrl":"https://doi.org/10.2147/TCRM.S473886","url":null,"abstract":"<p><strong>Objective: </strong>Our study evaluated the risk factors for new postoperative atrial fibrillation (POAF) by analyzing the data collected from patients who underwent first coronary artery bypass grafting (CABG).</p><p><strong>Methods: </strong>Our study retrospectively collected data from January 2021 to December 2023 at Changzhi People's Hospital. The perioperative period data were collected, and logistic regression was used to analyze the independent predictors of the occurrence of POAF after CABG and the related predictive values of risk factors were analyzed by using the subjects' work characteristic curve (ROC).</p><p><strong>Results: </strong>A total of 169 patients were included, and there are 45 patients in the POAF group, with an incidence of 26.6%, and 124 in the non-POAF group. The POAF group was significantly higher than the non-POAF group in terms of age (69.2±8.8 years vs 62.3±9.3 years) and preoperative LAD (42.7±7.2mm vs 36.8±5.5mm), and the difference was significant (P<0.05). Preoperative HDL-C in the POAF group were lower than non-POAF group (1.0±0.5 mmol/l vs 1.4±0.7 mmol/l, P<0.05). The logistic regression analysis revealed a significant correlation between age, LAD, HDL-C and the occurrence of POAF (P<0.05). According to the ROC curve analysis, age >64.5 years, LAD >41mm, and HDL-C <0.9 mmol/l were the cut-off values for predicting the occurrence of POAF (AUC1=0.733; AUC2=0.741; AUC3=0.647, P < 0.05). The combined age + LAD + HDL-C (AUC = 0.755; P < 0.05) had a higher diagnostic value and high sensitivity.</p><p><strong>Conclusion: </strong>The age, LAD, and HDL-C are independent risk factors for the POAF after CABG, and clinicians should assess these risk factors as much as possible when managing patients in the perioperative period and make corresponding measures to prevent the development of POAF.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"20 ","pages":"711-718"},"PeriodicalIF":2.8,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11456735/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142393556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of Influencing Factors and Construction of Predictive Model for Persistent Cough After Lung Cancer Resection Under Thoracoscopy. 胸腔镜下肺癌切除术后持续咳嗽的影响因素分析与预测模型构建
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-10-01 eCollection Date: 2024-01-01 DOI: 10.2147/TCRM.S464307
Jingling Lan, Xia Lin, Li Liu

Objective: This study aims to explore the influencing factors of cough after pulmonary resection (CAP) after thoracoscopic lung resection in lung cancer patients and to develop a predictive model.

Methods: A total of 374 lung cancer patients who underwent lung resection in our hospital from March 2020 to October 2023 were randomly divided into a modeling group (n=262) and a validation group (n=112). Based on the occurrence of CAP in the modeling group, the patients were divided into a CAP group (n=85) and a non-CAP group (n=177). Multivariate Logistic regression analysis was used to identify the influencing factors of CAP in lung cancer patients. A nomogram model for predicting the risk of CAP was constructed using R4.3.1. The consistency of the model's predictions was evaluated, and a clinical decision curve (DCA) was drawn to assess the clinical utility of the nomogram. The predictive performance of the model was evaluated using ROC curves and the Hosmer-Lemeshow test.

Results: Multivariate Logistic regression analysis showed that smoking history (OR=6.285, 95% CI: 3.031-13.036), preoperative respiratory function training (OR=20.293, 95% CI: 7.518-54.779), surgical scope (OR=20.667, 95% CI: 7.734-55.228), and peribronchial lymph node dissection (OR=5.883, 95% CI: 2.829-12.235) were significant influencing factors of CAP in lung cancer patients (P<0.05). ROC curves indicated good discriminatory power of the model, and the Hosmer-Lemeshow test showed a high degree of agreement between predicted and actual probabilities. The DCA curve revealed that the nomogram model had high clinical value when the high-risk threshold was between 0.08 and 0.98.

Conclusion: The nomogram model based on smoking history, preoperative respiratory function training, surgical scope, and peribronchial lymph node dissection has high predictive performance for CAP in lung cancer patients. It is useful for clinical prediction, guiding preoperative preparation, and postoperative care.

研究目的本研究旨在探讨肺癌患者胸腔镜肺切除术后咳嗽(CAP)的影响因素,并建立预测模型:方法:将2020年3月至2023年10月在我院接受肺切除术的374例肺癌患者随机分为建模组(n=262)和验证组(n=112)。根据建模组中 CAP 的发生率,将患者分为 CAP 组(n=85)和非 CAP 组(n=177)。多变量逻辑回归分析用于确定肺癌患者 CAP 的影响因素。使用 R4.3.1 建立了预测 CAP 风险的提名图模型。对模型预测的一致性进行了评估,并绘制了临床决策曲线(DCA)以评估提名图的临床实用性。使用 ROC 曲线和 Hosmer-Lemeshow 检验对模型的预测性能进行了评估:多变量逻辑回归分析显示,吸烟史(OR=6.285,95% CI:3.031-13.036)、术前呼吸功能训练(OR=20.293,95% CI:7.518-54.779)、手术范围(OR=20.667,95% CI:7.734-55.228)、支气管周围淋巴结清扫(OR=5.883,95% CI:2.829-12.235)是肺癌患者 CAP 的显著影响因素(PConclusion:基于吸烟史、术前呼吸功能训练、手术范围和支气管周围淋巴结清扫的提名图模型对肺癌患者的 CAP 具有较高的预测能力。它有助于临床预测、指导术前准备和术后护理。
{"title":"Analysis of Influencing Factors and Construction of Predictive Model for Persistent Cough After Lung Cancer Resection Under Thoracoscopy.","authors":"Jingling Lan, Xia Lin, Li Liu","doi":"10.2147/TCRM.S464307","DOIUrl":"10.2147/TCRM.S464307","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to explore the influencing factors of cough after pulmonary resection (CAP) after thoracoscopic lung resection in lung cancer patients and to develop a predictive model.</p><p><strong>Methods: </strong>A total of 374 lung cancer patients who underwent lung resection in our hospital from March 2020 to October 2023 were randomly divided into a modeling group (n=262) and a validation group (n=112). Based on the occurrence of CAP in the modeling group, the patients were divided into a CAP group (n=85) and a non-CAP group (n=177). Multivariate Logistic regression analysis was used to identify the influencing factors of CAP in lung cancer patients. A nomogram model for predicting the risk of CAP was constructed using R4.3.1. The consistency of the model's predictions was evaluated, and a clinical decision curve (DCA) was drawn to assess the clinical utility of the nomogram. The predictive performance of the model was evaluated using ROC curves and the Hosmer-Lemeshow test.</p><p><strong>Results: </strong>Multivariate Logistic regression analysis showed that smoking history (OR=6.285, 95% CI: 3.031-13.036), preoperative respiratory function training (OR=20.293, 95% CI: 7.518-54.779), surgical scope (OR=20.667, 95% CI: 7.734-55.228), and peribronchial lymph node dissection (OR=5.883, 95% CI: 2.829-12.235) were significant influencing factors of CAP in lung cancer patients (P<0.05). ROC curves indicated good discriminatory power of the model, and the Hosmer-Lemeshow test showed a high degree of agreement between predicted and actual probabilities. The DCA curve revealed that the nomogram model had high clinical value when the high-risk threshold was between 0.08 and 0.98.</p><p><strong>Conclusion: </strong>The nomogram model based on smoking history, preoperative respiratory function training, surgical scope, and peribronchial lymph node dissection has high predictive performance for CAP in lung cancer patients. It is useful for clinical prediction, guiding preoperative preparation, and postoperative care.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"20 ","pages":"701-709"},"PeriodicalIF":2.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11453154/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Dexmedetomidine on Hemodynamics, Plasma Catecholamine Levels, and Delirium Incidence Among Intubated Patients in the ICU--A Randomized Controlled Trial. 右美托咪定对 ICU 插管患者血液动力学、血浆儿茶酚胺水平和谵妄发生率的影响--一项随机对照试验。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-09-30 eCollection Date: 2024-01-01 DOI: 10.2147/TCRM.S471229
Li Qiao, Zheng Wang, Jian Shen, Xiaohui Xing, Hongxun Yuan

Objective: To investigate the impact of various sedative medications on hemodynamics and plasma levels of epinephrine (E) and norepinephrine (NE) in mechanically ventilated patients postoperatively in the intensive care unit (ICU).

Methods: Ninety-seven patients admitted to the ICU undergoing postoperative mechanical ventilation with tracheal intubation and continuous analgesic sedation following general anesthesia were randomly assigned to either the observation group (dexmedetomidine) (n = 49) or the control group (propofol) (n = 48) in this randomized controlled trial. Upon transfer to the ICU, vital signs (heart rate [HR], respiratory rate [RR], mean arterial pressure [MAP]) were recorded prior to the initiation of the sedation treatment (T0), at one-hour post sedation (T1) and two hours following tracheal extubation (T2), plasma levels of epinephrine (E) and norepinephrine (NE) were measured at these time points. The incidence of delirium was recorded in both groups.

Results: MAP between the two groups at both T0 and T1 At T2 plasma NE and HR were found to be lower in the observation group compared to the control group (P < 0.001). Among the patients receiving antihypertensive medication in the ICU, NE levels were significantly lower in the observation group compared to the control group (P = 0.019) Among the patients not receiving antihypertensive medication, both NE (P < 0.001) and MAP (P = 0.001) levels were lower in the observation group compared to the control group. The incidence of delirium in the observation group (dexmedetomidine) was not significantly different from that in the control group (propofol).

Conclusion: With dexmedetomidine sedation, blood pressure fluctuated less, plasma catecholamine levels were lower, and sympathetic inhibition was stronger in patients before and after extubation. However, it did not significantly reduce the incidence of postoperative delirium.

目的研究各种镇静药物对重症监护病房(ICU)术后机械通气患者的血液动力学以及血浆中肾上腺素(E)和去甲肾上腺素(NE)水平的影响:在这项随机对照试验中,97名在全身麻醉后接受气管插管和持续镇痛镇静的术后机械通气患者被随机分配到观察组(右美托咪定)(49人)或对照组(异丙酚)(48人)。转入重症监护室后,在镇静治疗开始前(T0)、镇静后一小时(T1)和气管拔管后两小时(T2)记录生命体征(心率[HR]、呼吸频率[RR]、平均动脉压[MAP]),并在这些时间点测量血浆中肾上腺素(E)和去甲肾上腺素(NE)的水平。记录两组患者的谵妄发生率:结果:两组患者在 T0 和 T1 时的血压均低于对照组(P<0.001)。在重症监护室接受降压药物治疗的患者中,观察组的 NE 水平明显低于对照组(P = 0.019)。观察组(右美托咪定)与对照组(异丙酚)的谵妄发生率无明显差异:结论:右美托咪定镇静后,患者在拔管前后的血压波动较小,血浆儿茶酚胺水平较低,交感神经抑制作用较强。结论:使用右美托咪定镇静剂后,拔管前后患者的血压波动较小,血浆儿茶酚胺水平较低,交感神经抑制作用较强,但并未明显降低术后谵妄的发生率。
{"title":"Impact of Dexmedetomidine on Hemodynamics, Plasma Catecholamine Levels, and Delirium Incidence Among Intubated Patients in the ICU--A Randomized Controlled Trial.","authors":"Li Qiao, Zheng Wang, Jian Shen, Xiaohui Xing, Hongxun Yuan","doi":"10.2147/TCRM.S471229","DOIUrl":"10.2147/TCRM.S471229","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the impact of various sedative medications on hemodynamics and plasma levels of epinephrine (E) and norepinephrine (NE) in mechanically ventilated patients postoperatively in the intensive care unit (ICU).</p><p><strong>Methods: </strong>Ninety-seven patients admitted to the ICU undergoing postoperative mechanical ventilation with tracheal intubation and continuous analgesic sedation following general anesthesia were randomly assigned to either the observation group (dexmedetomidine) (n = 49) or the control group (propofol) (n = 48) in this randomized controlled trial. Upon transfer to the ICU, vital signs (heart rate [HR], respiratory rate [RR], mean arterial pressure [MAP]) were recorded prior to the initiation of the sedation treatment (T0), at one-hour post sedation (T1) and two hours following tracheal extubation (T2), plasma levels of epinephrine (E) and norepinephrine (NE) were measured at these time points. The incidence of delirium was recorded in both groups.</p><p><strong>Results: </strong>MAP between the two groups at both T0 and T1 At T2 plasma NE and HR were found to be lower in the observation group compared to the control group (<i>P</i> < 0.001). Among the patients receiving antihypertensive medication in the ICU, NE levels were significantly lower in the observation group compared to the control group (<i>P = 0.019</i>) Among the patients not receiving antihypertensive medication, both NE (P < <i>0.001</i>) and MAP (P = <i>0.001</i>) levels were lower in the observation group compared to the control group. The incidence of delirium in the observation group (dexmedetomidine) was not significantly different from that in the control group (propofol).</p><p><strong>Conclusion: </strong>With dexmedetomidine sedation, blood pressure fluctuated less, plasma catecholamine levels were lower, and sympathetic inhibition was stronger in patients before and after extubation. However, it did not significantly reduce the incidence of postoperative delirium.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"20 ","pages":"689-700"},"PeriodicalIF":2.8,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11451452/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of Bispectral Index Monitoring on Outcomes in Spinal Cord Stimulation for Chronic Disorders of Consciousness. 双光谱指数监测对脊髓刺激治疗慢性意识障碍疗效的影响
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-09-27 eCollection Date: 2024-01-01 DOI: 10.2147/TCRM.S478489
Xuanling Chen, Xuewei Qin, Yutong Zhuang, Zhengqian Li, Zhenhu Liang, Hua Zhang, Lan Yao, Xiaoli Li, Jianghong He, Xiangyang Guo

Objective: To observe whether maintaining the appropriate depth of anesthesia with Bispectral Index (BIS) can improve the prognosis of Spinal Cord stimulation (SCS) implantation in patients with chronic Disorders of consciousness (DoC).

Methods: 103 patients with DoC undergoing SCS implantation were reviewed, and 83 patients with DoC were included according to the standard of inclusion and exclusion Criteria. Patients were divided into a BIS group (n =45) and a non-BIS group (n =38) according to whether BIS monitoring was used during the operation. The depth of anesthesia in the BIS group was maintained between 40-60. The anesthesiologist adjusted the depth of anesthesia in the non-BIS group according to clinical experience. Relevant information such as disease course, cause, anesthesia time, and operation time were collected. Preoperative CRS-R(preoperative) score, postoperative CRS-R(24h), and postoperative CRS-R(3m) changes were collected.

Results: The CRS-R(3m) score in the BIS group was higher than that in the non-BIS group (preoperative), and the difference was statistically significant (P < 0.05). In CRS-R (24h), the BIS group was higher than the non-BIS group, and the difference was statistically significant (X2=8.787, P =0.004). The improvement of consciousness was included in the multivariate Logistic regression analysis model, and it was found that the thalamus was an independent factor affecting the improvement of consciousness (P < 0.05). During follow-up, 1 patient in the BIS group had a decrease in consciousness from MCS- to VS/ UWS and 2 patients in the non-BIS group died during follow-up.

Conclusion: Patients can be benefit in hearing in CRS-R (24h). We recommend the use of BIS to monitor the depth of anesthesia in patients with DoC to improve patient outcomes.

目的方法:回顾性分析103例接受脊髓刺激术(SCS)的DoC患者,根据纳入和排除标准纳入83例DoC患者。根据手术中是否使用 BIS 监测,将患者分为 BIS 组(n =45)和非 BIS 组(n =38)。BIS 组的麻醉深度保持在 40-60 之间。麻醉师根据临床经验调整非 BIS 组的麻醉深度。收集病程、病因、麻醉时间和手术时间等相关信息。收集术前 CRS-R(术前)评分、术后 CRS-R(24h)和术后 CRS-R(3m)的变化情况:结果:BIS 组的 CRS-R(3m)评分高于非 BIS 组(术前),差异有统计学意义(P < 0.05)。在 CRS-R(24 小时)中,BIS 组高于非 BIS 组,差异有统计学意义(X2=8.787,P=0.004)。意识改善情况被纳入多变量 Logistic 回归分析模型,结果发现丘脑是影响意识改善的独立因素(P < 0.05)。随访期间,BIS组有1名患者的意识从MCS-降至VS/ UWS,非BIS组有2名患者在随访期间死亡:结论:CRS-R(24 小时)可使患者的听力获益。我们建议使用 BIS 监测 DoC 患者的麻醉深度,以改善患者的预后。
{"title":"The Impact of Bispectral Index Monitoring on Outcomes in Spinal Cord Stimulation for Chronic Disorders of Consciousness.","authors":"Xuanling Chen, Xuewei Qin, Yutong Zhuang, Zhengqian Li, Zhenhu Liang, Hua Zhang, Lan Yao, Xiaoli Li, Jianghong He, Xiangyang Guo","doi":"10.2147/TCRM.S478489","DOIUrl":"10.2147/TCRM.S478489","url":null,"abstract":"<p><strong>Objective: </strong>To observe whether maintaining the appropriate depth of anesthesia with Bispectral Index (BIS) can improve the prognosis of Spinal Cord stimulation (SCS) implantation in patients with chronic Disorders of consciousness (DoC).</p><p><strong>Methods: </strong>103 patients with DoC undergoing SCS implantation were reviewed, and 83 patients with DoC were included according to the standard of inclusion and exclusion Criteria. Patients were divided into a BIS group (n =45) and a non-BIS group (n =38) according to whether BIS monitoring was used during the operation. The depth of anesthesia in the BIS group was maintained between 40-60. The anesthesiologist adjusted the depth of anesthesia in the non-BIS group according to clinical experience. Relevant information such as disease course, cause, anesthesia time, and operation time were collected. Preoperative CRS-R<sub>(preoperative)</sub> score, postoperative CRS-R<sub>(24h),</sub> and postoperative CRS-R<sub>(3m)</sub> changes were collected.</p><p><strong>Results: </strong>The CRS-R(3m) score in the BIS group was higher than that in the non-BIS group <sub>(preoperative)</sub>, and the difference was statistically significant (P < 0.05). In CRS-R <sub>(24h)</sub>, the BIS group was higher than the non-BIS group, and the difference was statistically significant (X<sup>2</sup>=8.787, P =0.004). The improvement of consciousness was included in the multivariate Logistic regression analysis model, and it was found that the thalamus was an independent factor affecting the improvement of consciousness (P < 0.05). During follow-up, 1 patient in the BIS group had a decrease in consciousness from MCS<sup>-</sup> to VS/ UWS and 2 patients in the non-BIS group died during follow-up.</p><p><strong>Conclusion: </strong>Patients can be benefit in hearing in CRS-R <sub>(24h)</sub>. We recommend the use of BIS to monitor the depth of anesthesia in patients with DoC to improve patient outcomes.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"20 ","pages":"677-687"},"PeriodicalIF":2.8,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444212/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142362124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frailty Predicts in-Hospital Death in Traumatic Brain Injury Patients: A Retrospective Cohort Study. 虚弱预测创伤性脑损伤患者的院内死亡:一项回顾性队列研究
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-09-23 eCollection Date: 2024-01-01 DOI: 10.2147/TCRM.S475412
Hua Liu, Wenxi Wu, Min Xu, Xiaoyang Ling, Wei Lu, Feng Cheng, Jian Wang

Background and aim: Traumatic brain injury (TBI) is a severe public health problem in elderly patients, and frailty is associated with higher mortality rates in older patients. This study aims to assess the prognostic value of frailty in patients with TBI.

Methods: Clinical data from 348 TBI patients treated at Affiliated Kunshan Hospital of Jiangsu University and Kunshan Hospital of Traditional Chinese Medicine between December 2018 and December 2020 were retrospectively collected. Univariate and multivariate logistic regression analyses were used to determine risk factors affecting in-hospital mortality, and receiver operating characteristic (ROC) curves were plotted to assess the discriminatory power of the frailty index. Frailty was assessed using the FRAIL scale, where FRAIL stands for Fatigue, Resistance, Ambulation, Illness, and Loss of weight, with each item scored as 0 or 1.

Results: Using the FRIAL questionnaire, 122 patients had low frailty and 226 had high frailty. Multivariate logistic regression analysis showed that high frailty was a risk factor for in-hospital mortality in TBI patients (P<0.001, OR=2.012 [1.788-2.412]). The proportion of infections occurring in the two groups was statistically different (P=0.015), with severely infected TBI patients being more likely to develop complications. The ROC curve showed an area under the curve for the FRAIL score of 0.845 [0.752-0.938].

Conclusion: Frailty is an important risk factor for in-hospital mortality in elderly TBI patients, and more attention should be paid to patients with high levels of frailty. Clinicians should consider the degree of frailty when assessing TBI and making treatment decisions.

背景和目的:创伤性脑损伤(TBI)是老年患者的一个严重公共卫生问题,而虚弱与老年患者较高的死亡率有关。本研究旨在评估体弱对创伤性脑损伤患者的预后价值:回顾性收集2018年12月至2020年12月期间江苏大学附属昆山医院和昆山市中医院收治的348例创伤性脑损伤患者的临床数据。采用单变量和多变量逻辑回归分析来确定影响院内死亡率的风险因素,并绘制接收器操作特征曲线(ROC)来评估虚弱指数的判别能力。虚弱程度采用FRAIL量表进行评估,FRAIL代表疲劳、抵抗力、行动能力、疾病和体重减轻,每个项目的评分为0或1:根据 FRIAL 问卷,122 名患者为低度虚弱,226 名患者为高度虚弱。多变量逻辑回归分析表明,高度虚弱是导致创伤性脑损伤患者院内死亡率的一个风险因素:虚弱是老年创伤性脑损伤患者院内死亡的一个重要风险因素,应更多地关注虚弱程度高的患者。临床医生在评估创伤性脑损伤并做出治疗决定时,应考虑患者的虚弱程度。
{"title":"Frailty Predicts in-Hospital Death in Traumatic Brain Injury Patients: A Retrospective Cohort Study.","authors":"Hua Liu, Wenxi Wu, Min Xu, Xiaoyang Ling, Wei Lu, Feng Cheng, Jian Wang","doi":"10.2147/TCRM.S475412","DOIUrl":"https://doi.org/10.2147/TCRM.S475412","url":null,"abstract":"<p><strong>Background and aim: </strong>Traumatic brain injury (TBI) is a severe public health problem in elderly patients, and frailty is associated with higher mortality rates in older patients. This study aims to assess the prognostic value of frailty in patients with TBI.</p><p><strong>Methods: </strong>Clinical data from 348 TBI patients treated at Affiliated Kunshan Hospital of Jiangsu University and Kunshan Hospital of Traditional Chinese Medicine between December 2018 and December 2020 were retrospectively collected. Univariate and multivariate logistic regression analyses were used to determine risk factors affecting in-hospital mortality, and receiver operating characteristic (ROC) curves were plotted to assess the discriminatory power of the frailty index. Frailty was assessed using the FRAIL scale, where FRAIL stands for Fatigue, Resistance, Ambulation, Illness, and Loss of weight, with each item scored as 0 or 1.</p><p><strong>Results: </strong>Using the FRIAL questionnaire, 122 patients had low frailty and 226 had high frailty. Multivariate logistic regression analysis showed that high frailty was a risk factor for in-hospital mortality in TBI patients (P<0.001, OR=2.012 [1.788-2.412]). The proportion of infections occurring in the two groups was statistically different (P=0.015), with severely infected TBI patients being more likely to develop complications. The ROC curve showed an area under the curve for the FRAIL score of 0.845 [0.752-0.938].</p><p><strong>Conclusion: </strong>Frailty is an important risk factor for in-hospital mortality in elderly TBI patients, and more attention should be paid to patients with high levels of frailty. Clinicians should consider the degree of frailty when assessing TBI and making treatment decisions.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"20 ","pages":"665-675"},"PeriodicalIF":2.8,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11430268/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142354289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Performance of Machine Learning Algorithms in Predicting Prolonged Mechanical Ventilation in Patients with Blunt Chest Trauma. 机器学习算法在预测胸部钝挫伤患者机械通气时间延长方面的性能。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-09-20 eCollection Date: 2024-01-01 DOI: 10.2147/TCRM.S482662
Yifei Chen, Xiaoning Lu, Yuefei Zhang, Yang Bao, Yong Li, Bing Zhang

Purpose: Mechanical ventilation (MV) is one of the most common treatments for patients with blunt chest trauma (BCT) admitted to the intensive care unit (ICU). Our study aimed to investigate the performance of machine learning algorithms in predicting the prolonged duration of mechanical ventilation (PDMV) in patients with BCT.

Methods: In this single-center observational study, patients with BCT who were treated with MV through nasal or oral intubation were selected. PDMV was defined as the duration of mechanical ventilation ≥7 days after endotracheal intubation (normal vs prolonged MV; dichotomous outcomes). K-means was used to cluster data from the original cohort by an unsupervised learning method. Multiple machine learning algorithms were used to predict DMV categories. The most significant predictors were identified by feature importance analysis. Finally, a decision tree based on the chi-square automatic interaction detection (CHAID) algorithm was developed to study the cutoff points of predictors in clinical decision-making.

Results: A total of 426 patients and 35 characteristics were included. K-means clustering divided the cohort into two clusters (high risk and low risk). The area under the curve (AUC) of the DMV classification algorithms ranged from 0.753 to 0.923. The importance analysis showed that the volume of pulmonary contusion (VPC) was the most important feature to predict DMV. The prediction accuracy of the decision tree based on CHAID reached 86.4%.

Conclusion: Machine learning algorithms can predict PDMV in patients with BCT. Therefore, limited medical resources can be more appropriately allocated to BCT patients at risk for PDMV.

目的:机械通气(MV)是重症监护室(ICU)收治的钝性胸部创伤(BCT)患者最常用的治疗方法之一。我们的研究旨在探讨机器学习算法在预测 BCT 患者机械通气时间延长(PDMV)方面的性能:在这项单中心观察性研究中,我们选取了通过鼻腔或口腔插管接受 MV 治疗的 BCT 患者。PDMV定义为气管插管后机械通气时间≥7天(正常与延长MV;二分法结果)。采用无监督学习法对原始队列中的数据进行 K-means 聚类。使用多种机器学习算法预测 DMV 类别。通过特征重要性分析确定了最重要的预测因子。最后,开发了基于卡方自动交互检测(CHAID)算法的决策树,以研究临床决策中预测因子的临界点:结果:共纳入 426 名患者和 35 个特征。K-均值聚类将患者分为两组(高风险和低风险)。DMV 分类算法的曲线下面积(AUC)在 0.753 至 0.923 之间。重要度分析表明,肺挫伤体积(VPC)是预测 DMV 的最重要特征。基于 CHAID 的决策树的预测准确率达到了 86.4%:机器学习算法可以预测 BCT 患者的 PDMV。因此,有限的医疗资源可以更合理地分配给有 PDMV 风险的 BCT 患者。
{"title":"Performance of Machine Learning Algorithms in Predicting Prolonged Mechanical Ventilation in Patients with Blunt Chest Trauma.","authors":"Yifei Chen, Xiaoning Lu, Yuefei Zhang, Yang Bao, Yong Li, Bing Zhang","doi":"10.2147/TCRM.S482662","DOIUrl":"https://doi.org/10.2147/TCRM.S482662","url":null,"abstract":"<p><strong>Purpose: </strong>Mechanical ventilation (MV) is one of the most common treatments for patients with blunt chest trauma (BCT) admitted to the intensive care unit (ICU). Our study aimed to investigate the performance of machine learning algorithms in predicting the prolonged duration of mechanical ventilation (PDMV) in patients with BCT.</p><p><strong>Methods: </strong>In this single-center observational study, patients with BCT who were treated with MV through nasal or oral intubation were selected. PDMV was defined as the duration of mechanical ventilation ≥7 days after endotracheal intubation (normal vs prolonged MV; dichotomous outcomes). K-means was used to cluster data from the original cohort by an unsupervised learning method. Multiple machine learning algorithms were used to predict DMV categories. The most significant predictors were identified by feature importance analysis. Finally, a decision tree based on the chi-square automatic interaction detection (CHAID) algorithm was developed to study the cutoff points of predictors in clinical decision-making.</p><p><strong>Results: </strong>A total of 426 patients and 35 characteristics were included. K-means clustering divided the cohort into two clusters (high risk and low risk). The area under the curve (AUC) of the DMV classification algorithms ranged from 0.753 to 0.923. The importance analysis showed that the volume of pulmonary contusion (VPC) was the most important feature to predict DMV. The prediction accuracy of the decision tree based on CHAID reached 86.4%.</p><p><strong>Conclusion: </strong>Machine learning algorithms can predict PDMV in patients with BCT. Therefore, limited medical resources can be more appropriately allocated to BCT patients at risk for PDMV.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"20 ","pages":"653-664"},"PeriodicalIF":2.8,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11421453/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142354290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experts’ Opinion in Fabry Disease Management and the Unmet Medical Need: The Saudi Perspective 法布里病管理方面的专家意见和未满足的医疗需求:沙特视角
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-09-13 DOI: 10.2147/tcrm.s475744
Majid Alfadhel, Nouriya Al Sannaa, Rawda Sunbul, Huda Al-Khawaja, Sumayah Askandarani, Talal Alanzi, Mamoun Elawad, Konstantinos Fourtounas
Abstract: Fabry disease (FD) is an X-linked lysosomal storage disorder caused by α-galactosidase A gene mutations. Its global incidence ranges from 1:40,000 to 1:170,000. This expert review evaluates the available guidelines, the status of diagnosed but untreated patients with FD, and the challenges in diagnosing and managing FD in the Kingdom of Saudi Arabia (KSA). An advisory board meeting (ABM) was conducted in two phases, with a survey that aimed to receive insights on the current unmet needs in the management of patients with FD in November 2022, and a second, offline meeting in February 2023. The goal of this ABM was to discuss current unmet needs in the management of Fabry patients in the Kingdom of Saudi Arabia. In the first ABM, experts opined on the best practices in the diagnosis, screening, and management of FD for healthcare professionals. These opinions on the management of FD relied on data from research and expert clinical judgments. In the second ABM, the same panel discussed different aspects of FD diagnosis, treatment, and management in the member countries of the Gulf Cooperation Council. The experts discussed the stigma associated with FD, patient awareness and knowledge, genetic screening, biomarkers, and home infusion therapy. They reviewed international guidelines and clinical criteria for enzyme replacement therapy (ERT). Furthermore, they also discussed the diagnosis of FD in men and women, the current guidelines followed for monitoring patients with FD, monitoring untreated patients with FD, Fabry Stabilization IndeX (FASTEX) as an assessment tool for the diagnosis of FD, FD management in KSA, challenges encountered while prescribing ERT in patients with FD, and the clinical criteria for starting ERT. The discussions led to the conclusion that currently, ERT is the only available therapy to manage FD and research should be focused on the early diagnosis and management of FD.

Keywords: classical, enzyme replacement therapy, Fabry disease, late-onset, monitoring, phenotype
摘要:法布里病(FD)是一种由α-半乳糖苷酶A基因突变引起的X连锁溶酶体储积症。其全球发病率从 1:40,000 到 1:170,000 不等。本专家综述评估了沙特阿拉伯王国(KSA)现有的指南、已确诊但未接受治疗的 FD 患者的状况以及诊断和管理 FD 所面临的挑战。咨询委员会会议(ABM)分两个阶段进行,2022 年 11 月进行了一次调查,旨在了解目前在 FD 患者管理方面尚未满足的需求,2023 年 2 月进行了第二次线下会议。本次 ABM 的目标是讨论沙特阿拉伯王国法布里患者管理方面目前尚未满足的需求。在第一次 ABM 中,专家们就 FD 的诊断、筛查和管理方面的最佳实践为医护人员提供了意见。这些关于 FD 管理的意见依赖于研究数据和专家的临床判断。在第二次预期成果管理会议上,同一小组讨论了海湾合作委员会成员国在 FD 诊断、治疗和管理方面的不同问题。专家们讨论了与 FD 相关的耻辱感、患者意识和知识、基因筛查、生物标记物和家庭输液疗法。他们回顾了酶替代疗法(ERT)的国际指南和临床标准。此外,他们还讨论了男性和女性的 FD 诊断、监测 FD 患者的现行指南、监测未经治疗的 FD 患者、作为 FD 诊断评估工具的法布里稳定指数(FASTEX)、KSA 的 FD 管理、为 FD 患者开具 ERT 处方时遇到的挑战以及开始 ERT 的临床标准。讨论得出的结论是,目前ERT是治疗法布里病的唯一可用疗法,研究重点应放在法布里病的早期诊断和管理上。关键词:经典、酶替代疗法、法布里病、晚发、监测、表型
{"title":"Experts’ Opinion in Fabry Disease Management and the Unmet Medical Need: The Saudi Perspective","authors":"Majid Alfadhel, Nouriya Al Sannaa, Rawda Sunbul, Huda Al-Khawaja, Sumayah Askandarani, Talal Alanzi, Mamoun Elawad, Konstantinos Fourtounas","doi":"10.2147/tcrm.s475744","DOIUrl":"https://doi.org/10.2147/tcrm.s475744","url":null,"abstract":"<strong>Abstract:</strong> Fabry disease (FD) is an X-linked lysosomal storage disorder caused by α-galactosidase A gene mutations. Its global incidence ranges from 1:40,000 to 1:170,000. This expert review evaluates the available guidelines, the status of diagnosed but untreated patients with FD, and the challenges in diagnosing and managing FD in the Kingdom of Saudi Arabia (KSA). An advisory board meeting (ABM) was conducted in two phases, with a survey that aimed to receive insights on the current unmet needs in the management of patients with FD in November 2022, and a second, offline meeting in February 2023. The goal of this ABM was to discuss current unmet needs in the management of Fabry patients in the Kingdom of Saudi Arabia. In the first ABM, experts opined on the best practices in the diagnosis, screening, and management of FD for healthcare professionals. These opinions on the management of FD relied on data from research and expert clinical judgments. In the second ABM, the same panel discussed different aspects of FD diagnosis, treatment, and management in the member countries of the Gulf Cooperation Council. The experts discussed the stigma associated with FD, patient awareness and knowledge, genetic screening, biomarkers, and home infusion therapy. They reviewed international guidelines and clinical criteria for enzyme replacement therapy (ERT). Furthermore, they also discussed the diagnosis of FD in men and women, the current guidelines followed for monitoring patients with FD, monitoring untreated patients with FD, Fabry Stabilization IndeX (FASTEX) as an assessment tool for the diagnosis of FD, FD management in KSA, challenges encountered while prescribing ERT in patients with FD, and the clinical criteria for starting ERT. The discussions led to the conclusion that currently, ERT is the only available therapy to manage FD and research should be focused on the early diagnosis and management of FD.<br/><br/><strong>Keywords:</strong> classical, enzyme replacement therapy, Fabry disease, late-onset, monitoring, phenotype<br/>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"7 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142227078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thromboelastography in Long-Term Antiplatelet Therapy for Patients Diagnosed with Benign Prostate Hyperplasia Undergoing Holmium Laser Enucleation of the Prostate: A Retrospective Study 接受前列腺钬激光去核术的良性前列腺增生患者在长期抗血小板治疗中的血栓弹性成像:一项回顾性研究
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-09-11 DOI: 10.2147/tcrm.s472153
Zhi-Bo Gu, Lei Qiu, Hua Zhu, Ming Lu, Jian-Gang Chen
Objective: To compare low- vs high-power HoLEP effects on coagulation in patients on antiplatelet (AP) therapy via thromboelastography (TEG).
Methods: 210 patients was retrospectively analyzed and stratificated into three discrete groups, specifically: Group A (AP therapy, high-power HoLEP, n = 72); Group B (AP therapy, low-power HoLEP, n=73); Group C (no AP therapy, low-power HoLEP, n = 65). Baseline characteristics and coagulation profiles via TEG were compared. Univariate and multivariate analyses were conducted to identify independent risk factors associated with hematuria. Furthermore, parameters such as IPSS, Qmax, post-void residual volume V2 and PSA levels were recorded during 1year follow-up.
Results: No differences in terms of baseline characteristics across all groups. Significant differences were observed in the duration of enucleation, morcellation, bladder irrigation, post-operative catheterization, length of hospital stay and the extent of hemoglobin reduction (F = 54.06, 8.54, 6.68, 9.24, 17.06, 5.97, p < 0.05). No differences were noted in postoperative hematuria, urine retention, transfusion rates, and SUI (x12 = 1.082 ; x22 = 0.197,; x3= 3.981;x42 = 0.816, p > 0.05). Univariate and multivariate analyses revealed that prostate volume emerged as an independent risk factor for hematuria (OR 1.080, 95% CI: 1.007– 1.158, p = 0.031). Clinical outcomes including Qmax, IPSS, V2, and PSA demonstrated significant enhancement during 1 year follow-up.
Conclusion: Compared to HP-HoLEP, LP-HoLEP effectively reduces surgical and subsequent processing times, decreases hospital stay duration, and diminishes hemoglobin decline, offering a viable option without discontinuing AP therapy.

Keywords: anti-platelet therapy, BPH, high power, HoLEP, low power
目的通过血栓弹性成像(TEG)比较低功率和高功率 HoLEP 对抗血小板(AP)治疗患者凝血功能的影响:A组(AP疗法,高功率HoLEP,n=72);B组(AP疗法,低功率HoLEP,n=73);C组(无AP疗法,低功率HoLEP,n=65)。通过 TEG 对基线特征和凝血情况进行了比较。进行了单变量和多变量分析,以确定与血尿相关的独立风险因素。此外,还记录了随访一年期间的 IPSS、Qmax、排尿后残余尿量 V2 和 PSA 水平等参数:各组的基线特征无差异。在去核、切除、膀胱冲洗、术后导尿、住院时间和血红蛋白降低程度方面观察到显著差异(F = 54.06、8.54、6.68、9.24、17.06、5.97,P < 0.05)。术后血尿、尿潴留、输血率和 SUI 无差异(x12 = 1.082; x22 = 0.197,; x32 = 3.981;x42 = 0.816, p >0.05)。单变量和多变量分析显示,前列腺体积是血尿的独立危险因素(OR 1.080,95% CI:1.007- 1.158,P = 0.031)。包括Qmax、IPSS、V2和PSA在内的临床结果在1年的随访中均有显著改善:与 HP-HoLEP 相比,LP-HoLEP 可有效缩短手术时间和后续处理时间,缩短住院时间,减少血红蛋白下降,在不中断 AP 治疗的情况下提供了一种可行的选择。 关键词:抗血小板治疗;良性前列腺增生;高功率;HoLEP;低功率
{"title":"Thromboelastography in Long-Term Antiplatelet Therapy for Patients Diagnosed with Benign Prostate Hyperplasia Undergoing Holmium Laser Enucleation of the Prostate: A Retrospective Study","authors":"Zhi-Bo Gu, Lei Qiu, Hua Zhu, Ming Lu, Jian-Gang Chen","doi":"10.2147/tcrm.s472153","DOIUrl":"https://doi.org/10.2147/tcrm.s472153","url":null,"abstract":"<strong>Objective:</strong> To compare low- vs high-power HoLEP effects on coagulation in patients on antiplatelet (AP) therapy via thromboelastography (TEG).<br/><strong>Methods:</strong> 210 patients was retrospectively analyzed and stratificated into three discrete groups, specifically: Group A (AP therapy, high-power HoLEP, n = 72); Group B (AP therapy, low-power HoLEP, n=73); Group C (no AP therapy, low-power HoLEP, n = 65). Baseline characteristics and coagulation profiles via TEG were compared. Univariate and multivariate analyses were conducted to identify independent risk factors associated with hematuria. Furthermore, parameters such as IPSS, Qmax, post-void residual volume V<sub>2</sub> and PSA levels were recorded during 1year follow-up.<br/><strong>Results:</strong> No differences in terms of baseline characteristics across all groups. Significant differences were observed in the duration of enucleation, morcellation, bladder irrigation, post-operative catheterization, length of hospital stay and the extent of hemoglobin reduction (F = 54.06, 8.54, 6.68, 9.24, 17.06, 5.97, p &lt; 0.05). No differences were noted in postoperative hematuria, urine retention, transfusion rates, and SUI (x<sub>1</sub><sup>2</sup> = 1.082 ; x<sub>2</sub><sup>2</sup> = 0.197,; x<sub>3</sub><sup>2 </sup>= 3.981;x<sub>4</sub><sup>2</sup> = 0.816, p &gt; 0.05). Univariate and multivariate analyses revealed that prostate volume emerged as an independent risk factor for hematuria (OR 1.080, 95% CI: 1.007– 1.158, p = 0.031). Clinical outcomes including Qmax, IPSS, V<sub>2</sub>, and PSA demonstrated significant enhancement during 1 year follow-up.<br/><strong>Conclusion:</strong> Compared to HP-HoLEP, LP-HoLEP effectively reduces surgical and subsequent processing times, decreases hospital stay duration, and diminishes hemoglobin decline, offering a viable option without discontinuing AP therapy.<br/><br/><strong>Keywords:</strong> anti-platelet therapy, BPH, high power, HoLEP, low power<br/>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"1 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142227079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug Therapy Problems Identified by Clinical Pharmacists at a General Surgery Ward of an Academic Referral Hospital in Jordan 约旦一家学术转诊医院普通外科病房临床药剂师发现的药物治疗问题
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-09-11 DOI: 10.2147/tcrm.s465128
Hiba Al Fahmawi, Abla Albsoul-Younes, Mohammad Saleh, Mahmoud Abu-Abeeleh, Violet Kasabri
Introduction: Drug therapy problems (DTPs) continuously occur in hospitalized patients. This study aims to emphasize the role of clinical pharmacists in evaluating the DTP’s frequencies, causes, severity ratings, and contributing factors at a general surgery ward in Jordan.
Methods: This prospective observational study was conducted at one of the major teaching and referral hospitals in Jordan. Data were collected through clinical pharmacist reviews of paper and electronic medical records as well as patient interviews. DTPs were identified using Cipolle’s classification system and rated for severity on a scale of 10. Multiple linear regression was performed to identify factors contributing to DTPs. Drug classes primarily associated with DTPs were specified.
Results: During enrollment, a total of 80 patients were recruited in this study. The mean age of the enrolled patients was 52.35 ± 14.82 years, and 49 (61.25%) of them were males. Within the study period, 192 DTPs were identified by clinical pharmacists in 87.5%of the total recruited patients. The mean number of DTPs per patient was 2.40 ± 1.83. The most common categories of DTPs were “needs additional therapy” 46 (23.96%), “unnecessary drug therapy” 45 (23.44%), and “dosage too low” 39 (20.31%). Of the total DTPs, 127 (66.15%) were rated as severe. Multiple linear regression revealed that patients’ length of hospital stay and the number of current medications had a statistically significant effect on the number of DTPs identified during hospitalization. Endocrine and metabolic drugs 51 (26.56%) and cardiovascular drugs 36 (18.75%) were the most frequent classes of drugs contributing to DTPs.
Conclusion: DTPs are common in the general surgery ward. Clinical pharmacists can provide medication reviews for surgical patients to identify DTPs and rate their severities. Detecting risk factors for DTPs and the most common drug classes associated with them can assist in decision-making relevant to reducing DTPs in the surgical ward.

Keywords: drug therapy problems, clinical pharmacist, surgery ward, observational study
简介住院病人不断出现药物治疗问题(DTP)。本研究旨在强调临床药剂师在评估约旦普外科病房 DTP 发生频率、原因、严重程度和诱因方面的作用:这项前瞻性观察研究在约旦一家主要的教学和转诊医院进行。数据通过临床药剂师对纸质和电子病历的审查以及对患者的访谈收集。使用西波尔分类系统识别 DTP,并将严重程度分为 10 级。为确定导致 DTP 的因素,进行了多元线性回归。结果:本研究共招募了 80 名患者。入组患者的平均年龄为(52.35 ± 14.82)岁,其中 49 人(61.25%)为男性。在研究期间,临床药剂师在所有招募患者中发现了 192 例 DTP,占总人数的 87.5%。每位患者的 DTP 平均数量为 2.40 ± 1.83。最常见的 DTP 类别为 "需要额外治疗 "46 例(23.96%)、"不必要的药物治疗 "45 例(23.44%)和 "剂量过低 "39 例(20.31%)。在所有 DTP 中,127 项(66.15%)被评为严重。多元线性回归显示,患者住院时间的长短和当前药物的数量对住院期间发现的 DTP 数量有显著的统计学影响。内分泌和代谢药物 51 种(26.56%)和心血管药物 36 种(18.75%)是导致 DTPs 的最常见药物类别:结论:DTPs 在普外科病房很常见。临床药剂师可为外科病人提供药物审查,以识别 DTPs 并评定其严重程度。发现 DTPs 的风险因素以及与之相关的最常见药物类别,有助于做出相关决策,减少外科病房的 DTPs。
{"title":"Drug Therapy Problems Identified by Clinical Pharmacists at a General Surgery Ward of an Academic Referral Hospital in Jordan","authors":"Hiba Al Fahmawi, Abla Albsoul-Younes, Mohammad Saleh, Mahmoud Abu-Abeeleh, Violet Kasabri","doi":"10.2147/tcrm.s465128","DOIUrl":"https://doi.org/10.2147/tcrm.s465128","url":null,"abstract":"<strong>Introduction:</strong> Drug therapy problems (DTPs) continuously occur in hospitalized patients. This study aims to emphasize the role of clinical pharmacists in evaluating the DTP’s frequencies, causes, severity ratings, and contributing factors at a general surgery ward in Jordan.<br/><strong>Methods:</strong> This prospective observational study was conducted at one of the major teaching and referral hospitals in Jordan. Data were collected through clinical pharmacist reviews of paper and electronic medical records as well as patient interviews. DTPs were identified using Cipolle’s classification system and rated for severity on a scale of 10. Multiple linear regression was performed to identify factors contributing to DTPs. Drug classes primarily associated with DTPs were specified.<br/><strong>Results:</strong> During enrollment, a total of 80 patients were recruited in this study. The mean age of the enrolled patients was 52.35 ± 14.82 years, and 49 (61.25%) of them were males. Within the study period, 192 DTPs were identified by clinical pharmacists in 87.5%of the total recruited patients. The mean number of DTPs per patient was 2.40 ± 1.83. The most common categories of DTPs were “needs additional therapy” 46 (23.96%), “unnecessary drug therapy” 45 (23.44%), and “dosage too low” 39 (20.31%). Of the total DTPs, 127 (66.15%) were rated as severe. Multiple linear regression revealed that patients’ length of hospital stay and the number of current medications had a statistically significant effect on the number of DTPs identified during hospitalization. Endocrine and metabolic drugs 51 (26.56%) and cardiovascular drugs 36 (18.75%) were the most frequent classes of drugs contributing to DTPs.<br/><strong>Conclusion:</strong> DTPs are common in the general surgery ward. Clinical pharmacists can provide medication reviews for surgical patients to identify DTPs and rate their severities. Detecting risk factors for DTPs and the most common drug classes associated with them can assist in decision-making relevant to reducing DTPs in the surgical ward.<br/><br/><strong>Keywords:</strong> drug therapy problems, clinical pharmacist, surgery ward, observational study<br/>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"12 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142227080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia COVID-19 肺炎重症患者接受非减量肝素治疗的治疗范围时间
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-09-10 DOI: 10.2147/tcrm.s476187
Tereza Romanová, Filip Burša, Peter Sklienka, Jiří Sagan, Michelle Vaňková, Denis Buršík, Markéta Bílená, Martin Pulcer, Michal Burda, Jan Máca
Purpose: Anticoagulation therapy aims to improve the outcome of critically ill patients with severe COVID-19-associated pneumonia. Activated partial thromboplastin time (aPTT) is commonly used to maintain the target therapeutic range of continuous infusion of unfractionated heparin (UFH). The UFH infusion efficacy can be evaluated by determining the time in therapeutic range (TTR) using a modified Rosendaal method. The present study’s primary aim was to evaluate TTR based on the aPTT in critically ill patients with severe forms of COVID-19 pneumonia and its influence on survival. The secondary aim was to evaluate the time spent above (TATR) and below the therapeutic range (TBTR).
Patients and Methods: We performed a retrospective analysis of critically ill patients with COVID-19-associated pneumonia. All patients received a continuous infusion of UFH from the 2nd to 8th day since admission to the ICU. TTR, TATR, and TBTR were calculated using the modified Rosendaal method, and survival days were analyzed by regression (censored after 60 days).
Results: Of 103 patients, the median TTR was 49% (IQR 38– 63%), TATR 11% (IQR 5– 20%), and TBTR 33% (IQR 22– 51%). The regression analysis indicated a positive impact of higher TTR and TATR on the number of survival days [β=0.598 (p=0.0367) and β=1.032 (p=0.0208), respectively] and a negative impact of higher TBTR [β=− 0.681 (p=0.0033)] on the number of survival days.
Conclusion: Higher TTR and TATR were associated with better survival of critically ill patients with a severe course of COVID-19-associated pneumonia. Higher TBTR was associated with worse survival in these patients.

Keywords: unfractionated heparin, COVID-19, pneumonia, critical care
目的:抗凝疗法旨在改善重症 COVID-19 相关肺炎患者的预后。活化部分凝血活酶时间(aPTT)通常用于维持持续输注非分数肝素(UFH)的目标治疗范围。使用改良的罗森达尔法确定治疗范围内时间(TTR)可评估 UFH 输注疗效。本研究的主要目的是根据 COVID-19 重症肺炎重症患者的 aPTT 评估 TTR 及其对存活率的影响。次要目的是评估高于(TATR)和低于(TBTR)治疗范围的时间:我们对 COVID-19 相关肺炎重症患者进行了回顾性分析。所有患者自进入重症监护室的第 2 天至第 8 天均持续输注 UFH。采用改良的Rosendaal方法计算TTR、TATR和TBTR,并通过回归分析生存天数(60天后进行删减):在 103 名患者中,中位 TTR 为 49%(IQR 38-63%),TATR 为 11%(IQR 5-20%),TBTR 为 33%(IQR 22-51%)。回归分析表明,TTR和TATR越高,对生存天数的影响越大[分别为β=0.598(P=0.0367)和β=1.032(P=0.0208)],而TBTR越高,对生存天数的影响越小[β=- 0.681(P=0.0033)]:结论:TTR和TATR越高,COVID-19相关肺炎重症患者的生存率越高。结论:TTR和TATR越高,COVID-19相关肺炎重症患者的存活率越高;TBTR越高,这些患者的存活率越低。
{"title":"Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia","authors":"Tereza Romanová, Filip Burša, Peter Sklienka, Jiří Sagan, Michelle Vaňková, Denis Buršík, Markéta Bílená, Martin Pulcer, Michal Burda, Jan Máca","doi":"10.2147/tcrm.s476187","DOIUrl":"https://doi.org/10.2147/tcrm.s476187","url":null,"abstract":"<strong>Purpose:</strong> Anticoagulation therapy aims to improve the outcome of critically ill patients with severe COVID-19-associated pneumonia. Activated partial thromboplastin time (aPTT) is commonly used to maintain the target therapeutic range of continuous infusion of unfractionated heparin (UFH). The UFH infusion efficacy can be evaluated by determining the time in therapeutic range (TTR) using a modified Rosendaal method. The present study’s primary aim was to evaluate TTR based on the aPTT in critically ill patients with severe forms of COVID-19 pneumonia and its influence on survival. The secondary aim was to evaluate the time spent above (TATR) and below the therapeutic range (TBTR).<br/><strong>Patients and Methods:</strong> We performed a retrospective analysis of critically ill patients with COVID-19-associated pneumonia. All patients received a continuous infusion of UFH from the 2nd to 8th day since admission to the ICU. TTR, TATR, and TBTR were calculated using the modified Rosendaal method, and survival days were analyzed by regression (censored after 60 days).<br/><strong>Results:</strong> Of 103 patients, the median TTR was 49% (IQR 38– 63%), TATR 11% (IQR 5– 20%), and TBTR 33% (IQR 22– 51%). The regression analysis indicated a positive impact of higher TTR and TATR on the number of survival days [β=0.598 (p=0.0367) and β=1.032 (p=0.0208), respectively] and a negative impact of higher TBTR [β=− 0.681 (p=0.0033)] on the number of survival days.<br/><strong>Conclusion:</strong> Higher TTR and TATR were associated with better survival of critically ill patients with a severe course of COVID-19-associated pneumonia. Higher TBTR was associated with worse survival in these patients.<br/><br/><strong>Keywords:</strong> unfractionated heparin, COVID-19, pneumonia, critical care<br/>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"89 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142227114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Therapeutics and Clinical Risk Management
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1